While there are many different components that come together to make human existence special, nothing quite does the job like our tendency of growing on a consistent basis. You see; when an individual is able to grow under all possible situations, they, almost as a ripple effect, go on to hit upon some huge milestones along the way. The same is proven by everything we have achieved so far, with one strong piece of testimony coming from an idea called technology. The reason why we give technology so much traction is, of course, predicated upon its unprecedented skill-set, but mind you, there is a lot more in play here. To contextualize the statement, we must acknowledge how the whole dynamic is also influenced by the manner in which those skills were used. In fact, the latter factor was really what went on to realize a spectrum-wide for the creation, including a pivotal appearance on our healthcare block. We call this one pivotal mainly because it came right when the sector was struggling to hold up against an obsolete structure. Now, technology, using its ingenious ideas, was successful in shaking up that reality, but even after doing so, it will continue to improve the healthcare picture in one way or the other. This pattern should only get stronger on the back of a recent funding.
Dr. B, a New York-based telehealth company that makes healthcare services available to people with financial limitations, has successfully secured over $8 million in seed financing. The round, which saw close participation from the likes of Lerer Hippeau, Founders Fund, and many others, is expected to fund the company’s bid of expanding access to everyday prescriptions through its new “Visitless Prescription” service. Founded in 2021, Dr. B actually started out as an online business that would match you with unused Covid 19 vaccines. In a ridiculously short period, it was able to work alongside more than 700 healthcare providers, and as a result, it ended up getting the vaccines to over 1 million people living across 37 states. Nevertheless, as vaccines become more readily available, Dr. B has prepared to take a timely step forward and add other stuff on the portfolio. At the moment, the company is offering a limited access to at-home Covid-19 treatments, starting with Paxlovid and molnupiravir.
“While Covid-19 antiviral pills have been available for several months and there is a lot of demand, many people still have a hard time accessing them because they require a prescription,” said Cyrus Massoumi, founder and CEO of Dr. B. “Patients need flexible options for getting that prescription, which is why we started by providing Covid-19 antiviral prescriptions.”
Beyond that, Dr. B is also planning to deliver treatments for various other conditions such as heart health, dermatology, reproductive care, and much more.
While the wider availability of treatments is certainly the driving factor, Dr. B, notably enough, wants to provide them at low cost, or on some instances, no cost at all. To avail the financial leeway, the individual will be asked to fill out a questionnaire regarding their monthly income and the overall financial position. If they are deemed as qualified, they can enjoy Dr. B’s telehealth facilities without having to pay anything at all.
